Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.
Authors: DeFronzo RA; University of Texas Health Sciences Center, Diabetes Division, 7703 Floyd Curl Drive, San Antonio, Texas 78229, USA. albarado@uthscsa.edu, Burant CF, Fleck P, Wilson C, Mekki Q, Pratley RE
Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2012 May; Vol. 97 (5), pp. 1615-22. Date of Electronic Publication: 2012 Mar 14.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1945-7197
DOI:10.1210/jc.2011-2243